When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Principia Biopharma (NASDAQ:PRNB) announces positive results from Part B of a Phase 2 clinical trial, BELIEVE-PV, evaluating oral BTK inhibitor rilzabrutinib in patients with pemphigus, a group of rare autoimmune disorders characterized by blisters or sores on the skin. The data were virtually presented at the American Academy of Dermatology Annual Meeting.
More news on: Principia Biopharma Inc., Healthcare stocks news,